An open-label phase 2 study treating patients with first or second relapse of multiple myeloma with carfilzomib, pomalidomide, and dexamethasone (KPd): SELECT study. - Perrot, Aurore; Delimpasi, Sosana; Spanoudakis, Emmanouil; Frølund, Ulf; Belotti, Angelo; Oriol, Albert; Moreau, Philippe; McFadden, Ian; Xia, Qing; Arora, Mukta; Dimopoulos, Meletios Athanasios (Leukemia & Lymphoma, 2024)